Tuttle Capital Management, LLC Gilead Sciences, Inc. Transaction History

Tuttle Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $302,397 - $344,567	-5,338 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $331,489 - $416,791	5,338 New	5,338 $337,000
Q3 2017 Nov 15, 2017	SELL	$72.11 - $85.47 $347,498 - $411,879	-4,819 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	4,819	4,819 $341,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.